{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:46:59Z","timestamp":1791316019239,"version":"4.3.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T00:00:00Z","timestamp":1413936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00228-014-1770-2","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T04:45:16Z","timestamp":1413953116000},"page":"85-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["N1-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin\u2013trimethoprim interaction"],"prefix":"10.1007","volume":"71","author":[{"given":"Fabian","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza A.","family":"Pontones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertold","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Mieth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hoier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Auge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renke","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Fromm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,22]]},"reference":[{"key":"1770_CR1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"KM Giacomini","year":"2010","unstructured":"Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9:215\u2013236","journal-title":"Nat Rev Drug Discov"},{"key":"1770_CR2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/pr.113.007518","volume":"65","author":"J K\u00f6nig","year":"2013","unstructured":"K\u00f6nig J, M\u00fcller F, Fromm MF (2013) Transporters and drug-drug interactions: important determinants of drug disposition and effects. Pharmacol Rev 65:944\u2013966","journal-title":"Pharmacol Rev"},{"key":"1770_CR3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","volume":"53","author":"KM Morrissey","year":"2013","unstructured":"Morrissey KM, Stocker SL, Wittwer MB, Xu L, Giacomini KM (2013) Renal transporters in drug development. Annu Rev Pharmacol Toxicol 53:503\u2013529","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1770_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1517\/17425255.2012.667401","volume":"8","author":"EI Lepist","year":"2012","unstructured":"Lepist EI, Ray AS (2012) Renal drug-drug interactions: what we have learned and where we are going. Expert Opin Drug Metab Toxicol 8:433\u2013448","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1770_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-642-14541-4_3","volume":"201","author":"AT Nies","year":"2011","unstructured":"Nies AT, Koepsell H, Damme K, Schwab M (2011) Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb Exp Pharmacol 201:105\u2013167","journal-title":"Handb Exp Pharmacol"},{"key":"1770_CR6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.mam.2012.11.004","volume":"34","author":"H Motohashi","year":"2013","unstructured":"Motohashi H, Inui K (2013) Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K. Mol Aspects Med 34:661\u2013668","journal-title":"Mol Aspects Med"},{"key":"1770_CR7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MNH.0b013e328363ffaf","volume":"22","author":"H Koepsell","year":"2013","unstructured":"Koepsell H (2013) Polyspecific organic cation transporters and their biomedical relevance in kidney. Curr Opin Nephrol Hypertens 22:533\u2013538","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1770_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2125.1987.tb03090.x","volume":"23","author":"A Somogyi","year":"1987","unstructured":"Somogyi A, Stockley C, Keal J, Rolan P, Bochner F (1987) Reduction of metformin renal tubular secretion by cimetidine in man. Br J Clin Pharmacol 23:545\u2013551","journal-title":"Br J Clin Pharmacol"},{"key":"1770_CR9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/clpt.2011.36","volume":"89","author":"H Kusuhara","year":"2011","unstructured":"Kusuhara H, Ito S, Kumagai Y, Jiang M, Shiroshita T, Moriyama Y, Inoue K, Yuasa H, Sugiyama Y (2011) Effects of a MATE protein inhibitor, pyrimethamine, on the renal elimination of metformin at oral microdose and at therapeutic dose in healthy subjects. Clin Pharmacol Ther 89:837\u2013844","journal-title":"Clin Pharmacol Ther"},{"key":"1770_CR10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/bcp.12079","volume":"76","author":"B Gr\u00fcn","year":"2013","unstructured":"Gr\u00fcn B, Kiessling MK, Burhenne J, Riedel KD, Weiss J, Rauch G, Haefeli WE, Czock D (2013) Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters. Br J Clin Pharmacol 76:787\u2013796","journal-title":"Br J Clin Pharmacol"},{"key":"1770_CR11","unstructured":"European Medicines Agency (2012) Guideline on the investigation of drug interactions. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2012\/07\/news_detail_001561.jsp&mid=WC0b01ac058004d5c1"},{"key":"1770_CR12","unstructured":"FDA (2012) Guidance for industry: drug interaction studies\u2014study design, data analysis, implications for dosing, and labeling recommendations (Draft Guidance). http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm064982.htm"},{"key":"1770_CR13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/clpt.2013.74","volume":"94","author":"KM Hillgren","year":"2013","unstructured":"Hillgren KM, Keppler D, Zur AA, Giacomini KM, Stieger B, Cass CE, Zhang L (2013) Emerging transporters of clinical importance: an update from the International Transporter Consortium. Clin Pharmacol Ther 94:52\u201363","journal-title":"Clin Pharmacol Ther"},{"key":"1770_CR14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/clpt.2012.138","volume":"92","author":"S Ito","year":"2012","unstructured":"Ito S, Kusuhara H, Kumagai Y, Moriyama Y, Inoue K, Kondo T, Nakayama H, Horita S, Tanabe K, Yuasa H, Sugiyama Y (2012) N-Methylnicotinamide is an endogenous probe for evaluation of drug-drug interactions involving multidrug and toxin extrusions (MATE1 and MATE2-K). Clin Pharmacol Ther 92:635\u2013641","journal-title":"Clin Pharmacol Ther"},{"key":"1770_CR15","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/carcin\/bgu174","volume":"35","author":"HC Bi","year":"2014","unstructured":"Bi HC, Pan YZ, Qiu JX, Krausz KW, Li F, Johnson CH, Jiang CT, Gonzalez FJ, Yu AM (2014) N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis. Carcinogenesis 35:2264\u20132272","journal-title":"Carcinogenesis"},{"key":"1770_CR16","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1124\/dmd.107.019075","volume":"36","author":"S Kitamura","year":"2008","unstructured":"Kitamura S, Nitta K, Tayama Y, Tanoue C, Sugihara K, Inoue T, Horie T, Ohta S (2008) Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver. Drug Metab Dispos 36:1202\u20131205","journal-title":"Drug Metab Dispos"},{"key":"1770_CR17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF01062963","volume":"19","author":"W Weber","year":"1991","unstructured":"Weber W, Toussaint S, Looby M, Nitz M, Kewitz H (1991) System analysis in multiple dose kinetics: evidence for saturable tubular reabsorption of the organic cation N1-methylnicotinamide in humans. J Pharmacokinet Biopharm 19:553\u2013574","journal-title":"J Pharmacokinet Biopharm"},{"key":"1770_CR18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bcp.2013.07.008","volume":"86","author":"F M\u00fcller","year":"2013","unstructured":"M\u00fcller F, K\u00f6nig J, Hoier E, Mandery K, Fromm MF (2013) Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine. Biochem Pharmacol 86:808\u2013815","journal-title":"Biochem Pharmacol"},{"key":"1770_CR19","doi-asserted-by":"crossref","first-page":"F997","DOI":"10.1152\/ajprenal.00431.2009","volume":"298","author":"M Schwabedissen HE","year":"2010","unstructured":"Schwabedissen HE M, Verstuyft C, Kroemer HK, Becquemont L, Kim RB (2010) Human multidrug and toxin extrusion 1 (MATE1\/SLC47A1) transporter: functional characterization, interaction with OCT2, and single nucleotide polymorphisms. Am J Physiol Renal Physiol 298:F997\u2013F1005","journal-title":"Am J Physiol Renal Physiol"},{"key":"1770_CR20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2014.66","volume":"86","author":"EI Lepist","year":"2014","unstructured":"Lepist EI, Zhang X, Hao J, Huang J, Kosaka A, Birkus G, Murray BP, Bannister R, Cihlar T, Huang Y, Ray AS (2014) Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat. Kidney Int 86:350\u2013357","journal-title":"Kidney Int"},{"key":"1770_CR21","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/AAC.01835-10","volume":"55","author":"F M\u00fcller","year":"2011","unstructured":"M\u00fcller F, K\u00f6nig J, Glaeser H, Schmidt I, Zolk O, Fromm MF, Maas R (2011) Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine. Antimicrob Agents Chemother 55:3091\u20133098","journal-title":"Antimicrob Agents Chemother"},{"key":"1770_CR22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejps.2012.02.014","volume":"46","author":"K Mandery","year":"2012","unstructured":"Mandery K, Balk B, Bujok K, Schmidt I, Fromm MF, Glaeser H (2012) Inhibition of hepatic uptake transporters by flavonoids. Eur J Pharm Sci 46:79\u201385","journal-title":"Eur J Pharm Sci"},{"key":"1770_CR23","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI30558","volume":"117","author":"Y Shu","year":"2007","unstructured":"Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA, Ianculescu AG, Yue L, Lo JC, Burchard EG, Brett CM, Giacomini KM (2007) Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 117:1422\u20131431","journal-title":"J Clin Invest"},{"key":"1770_CR24","first-page":"1876","volume":"101","author":"N Gyr","year":"1971","unstructured":"Gyr N, Berger W, Fridrich R, Denes A, Stalder GA (1971) Effect of dimethylbiguanide on stomach emptying and on oral glucose tolerance. Schweiz Med Wochenschr 101:1876\u20131879","journal-title":"Schweiz Med Wochenschr"},{"key":"1770_CR25","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1124\/dmd.113.055616","volume":"42","author":"A Kim","year":"2014","unstructured":"Kim A, Chung I, Yoon SH, Yu KS, Lim KS, Cho JY, Lee H, Jang IJ, Chung JY (2014) Effects of proton pump inhibitors on metformin pharmacokinetics and pharmacodynamics. Drug Metab Dispos 42:1174\u20131179","journal-title":"Drug Metab Dispos"},{"key":"1770_CR26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/clpt.2010.266","volume":"89","author":"SK Cho","year":"2011","unstructured":"Cho SK, Yoon JS, Lee MG, Lee DH, Lim LA, Park K, Park MS, Chung JY (2011) Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants. Clin Pharmacol Ther 89:416\u2013421","journal-title":"Clin Pharmacol Ther"},{"key":"1770_CR27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpba.2012.02.011","volume":"66","author":"GA Khan","year":"2012","unstructured":"Khan GA, Lindberg R, Grabic R, Fick J (2012) The development and application of a system for simultaneously determining anti-infectives and nasal decongestants using on-line solid-phase extraction and liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 66:24\u201332","journal-title":"J Pharm Biomed Anal"},{"key":"1770_CR28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpba.2007.06.003","volume":"45","author":"HN Mistri","year":"2007","unstructured":"Mistri HN, Jangid AG, Shrivastav PS (2007) Liquid chromatography tandem mass spectrometry method for simultaneous determination of antidiabetic drugs metformin and glyburide in human plasma. J Pharm Biomed Anal 45:97\u2013106","journal-title":"J Pharm Biomed Anal"},{"key":"1770_CR29","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/bmc.2673","volume":"26","author":"W Zhang","year":"2012","unstructured":"Zhang W, Han F, Zhao H, Lin ZJ, Huang QM, Weng N (2012) Determination of metformin in rat plasma by HILIC-MS\/MS combined with Tecan automation and direct injection. Biomed Chromatogr 26:1163\u20131169","journal-title":"Biomed Chromatogr"},{"key":"1770_CR30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1042\/bj0550170","volume":"55","author":"M Dixon","year":"1953","unstructured":"Dixon M (1953) The determination of enzyme inhibitor constants. Biochem J 55:170\u2013171","journal-title":"Biochem J"},{"key":"1770_CR31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1248\/bpb1978.6.787","volume":"6","author":"CK Shim","year":"1983","unstructured":"Shim CK, Sawada Y, Iga T, Hanano M (1983) Effect of experimental acute renal failure on intrinsic renal tubular secretory clearance of organic cations in rats. J Pharmacobiodyn 6:787\u2013789","journal-title":"J Pharmacobiodyn"},{"key":"1770_CR32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0031-6997(24)01372-3","volume":"50","author":"K Ito","year":"1998","unstructured":"Ito K, Iwatsubo T, Kanamitsu S, Ueda K, Suzuki H, Sugiyama Y (1998) Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver. Pharmacol Rev 50:387\u2013412","journal-title":"Pharmacol Rev"},{"key":"1770_CR33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.102.034140","volume":"302","author":"DS Wang","year":"2002","unstructured":"Wang DS, Jonker JW, Kato Y, Kusuhara H, Schinkel AH, Sugiyama Y (2002) Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J Pharmacol Exp Ther 302:510\u2013515","journal-title":"J Pharmacol Exp Ther"},{"key":"1770_CR34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/clpt.2012.145","volume":"92","author":"MF Fromm","year":"2012","unstructured":"Fromm MF (2012) Prediction of transporter-mediated drug-drug interactions using endogenous compounds. Clin Pharmacol Ther 92:546\u2013548","journal-title":"Clin Pharmacol Ther"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-014-1770-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-014-1770-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-014-1770-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T09:39:07Z","timestamp":1746437947000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-014-1770-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,22]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["1770"],"URL":"https:\/\/doi.org\/10.1007\/s00228-014-1770-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,22]]}}}